Targeting bacterial virulence not bugs could yield new meds say researchers
Compounds that leave pathogenic bacteria alive but harmless could yield antibiotics that are less likely to induce resistance development say the authors of a new study.
Archives for March 17, 2016
US FDA raises concerns about Lupin's Goa plant
The US FDA has criticised operations at a Lupin manufacturing plant in Goa, India.
Mexico office to bolster CRO Eurotrials' presence in Latin America
Eurotrials has opened an office in Mexico City in a bid the dominant CRO in the growing Mexican clinical research market.
Hikma: Ben Venue tech transfer and network investments to boost injectables biz
Hikma says the $82m pumped into its injectables network last year will be a factor in returning the sector to growth in 2016.
dispatches from DCAT Week '16
Big pharma interest in specialty drugs will fuel US market growth says IMS Health
The slowdown in developing markets has prompted many pharmaceutical firms to focus on specialty drugs according to an IMS Health analyst, who predicted that the trend will accelerate.
Miltenyi Biotec to help GSK automate R&D cell therapy production
GSK has called on German processing technology firm Miltenyi Biotec to help it automate its cell therapy manufacturing operations.
Covance launches app assessment service for sponsors
Covance has rolled out a consulting designed to help trial sponsors check that mobile apps they plan to use in clinical research meet with regulatory guidelines.
Dr Reddy's teams with API firm TR-Pharma to launch biosimilars in Turkey
Dr Reddy’s Laboratories and TR-Pharma have partnered to manufacture biosimilar pharmaceuticals for the Turkish market.